ROS in diabetic atria regulate SK2 degradation by Atrogin-1 through the NF-κB signaling pathway.

Atrial fibrillation Atrogin-1 Diabetes mellitus NF-κB ROS SK2

Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
07 Feb 2024
Historique:
received: 23 06 2023
revised: 13 01 2024
accepted: 19 01 2024
medline: 10 2 2024
pubmed: 10 2 2024
entrez: 9 2 2024
Statut: aheadofprint

Résumé

One of the independent risk factors for atrial fibrillation (AF) is diabetes mellitus (DM); however, the underlying mechanisms causing AF in DM are unknown. Our previous investigation indicated that the muscle-specific E3 ligase Atrogin-1 contributes to SK2 protein degradation in the atria of streptozotocin (STZ)-induced DM mice, increasing susceptibility to atrial arrhythmias. However, the underlying mechanism of Atrogin-1-mediated SK2 degradation and associated signaling pathways are unclear. The aim of this study was to elucidate the relationship among ROS, the NF-κB signaling pathway, and Atrogin-1 protein expression in the atrial myocardia of DM mice. We found that SK2 expression was downregulated comitant with increased reactive oxygen species (ROS) generation and enhanced NF-κB signaling activation in the atrial cardiomyocytes of DM mice. These observations were mimicked by exogenously applicating H

Identifiants

pubmed: 38336298
pii: S0021-9258(24)00111-X
doi: 10.1016/j.jbc.2024.105735
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105735

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Jian Xu and Dong Zhang, designed experiments and wrote the first draft of the manuscript. YiBo Ma, Yi Zhang, Hui Du, WenPing Luo and Ruxing Wang, provided important intellectual content. Fu Yi provided financial support and revised the manuscript. All authors critically reviewed, interpreted the data and approved the final version of the manuscript.

Auteurs

Jian Xu (J)

Department of Cardiovascular Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China; Department of Cardiology, The Sixth Medical Centre, Chinese PLA General Hospital, Beijing 100048, China.

Dong Zhang (D)

Department of Cardiovascular Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.

Yibo Ma (Y)

Department of Cardiovascular Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.

Hui Du (H)

Department of Cardiovascular Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.

Yi Wang (Y)

Department of Cardiovascular Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.

Wenping Luo (W)

Institute of Cardiovascular and Vascular Disease, Shaanxi University of Traditional Chinese Medicine, Xianyang 712000, China.

Ruxing Wang (R)

Department of Cardiology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China.

Fu Yi (F)

Department of Cardiovascular Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China. Electronic address: yi12fu56@126.com.

Classifications MeSH